Latest Insider Transactions at Virpax Pharmaceuticals, Inc. (VRPX)
This section provides a real-time view of insider transactions for Virpax Pharmaceuticals, Inc. (VRPX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Virpax Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Virpax Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 24
2022
|
Jerrold Sendrow Director |
BUY
Open market or private purchase
|
Direct |
4,500
+33.32%
|
$4,500
$1.29 P/Share
|
|
May 18
2022
|
Eric Floyd Director |
BUY
Open market or private purchase
|
Direct |
4,479
+35.84%
|
$4,479
$1.36 P/Share
|
|
May 18
2022
|
Anthony P. Mack Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
75,750
+23.07%
|
$75,750
$1.34 P/Share
|
|
Nov 22
2021
|
Jerrold Sendrow Director |
BUY
Open market or private purchase
|
Direct |
3,900
+46.4%
|
$11,700
$3.92 P/Share
|
|
Nov 18
2021
|
Anthony P. Mack Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
25,125
+12.44%
|
$75,375
$3.99 P/Share
|
|
Feb 17
2021
|
Thani Jambulingam Director |
BUY
Open market or private purchase
|
Direct |
100
+50.0%
|
$700
$7.16 P/Share
|
|
Feb 17
2021
|
Gary S Jacob Director |
BUY
Open market or private purchase
|
Direct |
3,500
+50.0%
|
$21,000
$6.79 P/Share
|